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Abstract 
Type 2 diabetes is a multifactorial disease caused by a complex interplay of multiple genetic variants and many 
environmental factors. With the recent genome-wide association (GWA) studies, the number of replicated 
common genetic variants associated with type 2 diabetes has rapidly increased. In this study, our aim was to 
determine the role of IL-10 polymorphism among patients with T2DM. A total of 120 Type 2 diabetes mellitus 
patients (67 males and 53 females) with an age mean ± SD (62.8333± 9.46052), FBS mean ± SD (310.0000± 
88.90737), family history (90 positive/ 30 negative to family history, Hypertension (86 positive/ 34 negative) 
and 120 non-diabetic controls (46 males and 74 females) of Iraqis ethnicity with an age mean ± SD (31.6583± 
11.51579). There was significant difference between the groups (T2DM patients and their control) (P = 0.001). 
And IL-10 gene polymorphism in each group was compared (CC, TT, CT). There is an association between the 
IL-10 (SNP rs 3021097 (C/T) gene polymorphism among T2DM patients and healthy people.  
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Introduction   
Diabetes is a non-communicable disease characterized by chronic hyperglycemia and disturbances in 
carbohydrates, lipids and proteins metabolism due to defects in insulin secretion and its action (Guillausseau et 
al., 2008). Type 2 diabetes mellitus is the most prevalent type of diabetes and is often caused by decreased 
insulin production by the pancreas, also known as non-insulin dependent diabetes mellitus (NIDDM) or adult-
onset diabetes, (Arababadi et al., 2009; Nosratabadi et al., 2009).T2DM also known as multifactorial disease 
caused by a complex interplay of multiple genetic variants and many environmental factors. Several genes 
influence the underline level of glucose tolerance and thereby contribute to overall susceptibility to T2DM (de 
Lorenzo et al., 2013). Genetic linkage analysis and association studies have identified several candidate genes 
contributing to T2DM. However, given the ethnic differences in life style, environmental factors as well as in the 
genetic background, it is important to examine polymorphisms related to T2DM in each ethnic group (Wilson et 
al., 2007; Yamada et al., 2006). 
Interleukin (IL-10) is a pleiotropic Th2 cytokine that is usually considered to have a role in the down 
regulation of cell mediated and cytotoxic inflammatory responses, thus being a potent anti-inflammatory 
mediator. It has been suggested that Th2 induced component of anti-β cell immunity is mediated principally by 
IL-10 (Lee et al., 1996; Lee et al., 1994). The gene encoding IL-10 has been mapped to chromosome 1q. Several 
polymorphic sites within the promoter region have been described, including two microsatellite polymorphisms 
and three biallelic polymorphisms at positions: −1082, −819, and −592 from the transcription start site (Eskdale 
et al., 1998; Turner et al., 1997). IL-10 promoter SNP genotype and haplotype frequencies appear to exhibit 
different distributions according to ethnicity (Moraes et al., 2003; Pyo et al., 2003; Urcelay et al., 2004). Genetic 
variants associated with risk of type 2 diabetes could potentially be useful for the prediction, prevention, and 
early treatment of the disease. The aim of this study was to examine the role of interleukin–10 (IL-10) gene in 
genetic susceptibility as risk factors for type 2 diabetes mellitus in a sample of Iraqis patient. 
 
Materials and methods 
This is a case–control study involving 120 T2DM patients (67 males and 53 females) with an age mean ± SD 
(62.8333± 9.46052), FBS mean ± SD (310.0000± 88.90737), family history (90 positive/ 30 negative to family 
history, Hypertension (86 positive/ 34 negative) and 120 non-diabetic controls (46 males and 74 females) of 
Iraqis ethnicity with an age mean ± SD (31.6583± 11.51579), were enrolled in this study and recruited at 
Baghdad teaching hospital, medical city, Baghdad, Iraq. T2DM patients, diagnosed according to American 
Diabetes Association criteria. 
The Ethics Committees of participating universities and university hospitals approved the study, and 
informed consent was obtained from all participants. Blood sampling (one ml of venous blood) was collected in 
EDTA tubes from each individual (patient or healthy control) and was stored as whole blood at -20oC for 
subsequent DNA isolation. Genomic DNA was isolated from whole blood according to Sambrook et al 1989 
(Shubeita, Sambrook, and McCormick, 1987). 
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Genotyping of IL-10- SNP -819 gene polymorphism  
One SNP rs 3021097 (C/T) in Il-10 -819 gene was genotyped among the participants groups in this study. The Il-
10 -819 C/T polymorphic region (rs 3021097) was amplified by polymerase chain reaction (PCR) using allele 
specific PCR technique as shown in Table 1. Three primers (two allele specific primers and common reverse 
primer) were designed based on the nucleotide sequence of a partial fragment (retrieved from the online dbSNP) 
of the gene containing the target SNP. The polymorphism was visualized by separating the DNA fragments in a 
2% agarose gel that was stained with ethidium bromide and illuminated by UV. To validate the PCR- allele 
specific results to validate the PCR- allele specific results. All primers used in this study were newly designed 
using Primer Blast online programme (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
 
Figure 1:   2% agarose gel electrophoresis for allele specific PCR for IL-10-819 gene (rs 3021097 C/T) M: 100 
bp DNA ladder from GeneDireX®. Lanes 1 and 2: PCR products upon using allele specific C primer and allele 
specific T primer, respectively. Heterozygous genotype will give positive reaction upon using both allele specific 
primers. However, homozygous genotype will give positive reaction upon using only one of these allele specific 
primers. 
 
Table 1: Primers sequences, PCR conditions, length of PCR products 
SNPs Primers sequences PCR Conditions Size of PCR 
Products 
digestion products 
Il-10 
SNP-819  C/T 
(rs #3021097) 
T-allele specific primer: 
F1: 5-CCC TTG TAC AGG TGA TGT AT C-3 
 
C-allele specific primer: 
F2: 5-CCC TTG TAC AGG TGA TGT AT T-3       
   
Common reverse primer: 
 
5- GGATGT GTTCCA GGCTCC T-3 
An initial denaturation  at 
95oC for 5 min  
-Then, 30 cycles each cycle 
consisted of denaturation at 
94oC for 60s, annealing at 
50 oC for 30s and extension 
at 72oC for 30 s.  
-A final extension at 72oC 
for 10min. 
Allele C: 232 bp  
Allele  T: 232 bp  
  
 
 
Statistical analysis of data 
Statistical analysis of data was done to correlate genotype distribution and allele frequencies were performed by 
SPSS package version 17. The frequencies of alleles, genotypes in different groups were compared using the 
Chi-squared test (X2), t-test were used to test the significance of results of quantitative variables. Odds ratio and 
95% confidence interval (95% CIs) were calculated for different studied parameters. The confidence interval (CI) 
at 95% was used to describe the amount of uncertainty associated with the samples (Greenfield et al., 2008; 
Szumilas, 2010).  The significance of the results was taken at the P < 0.05 level of significance. 
 
Results and Discussion 
Our results approved there was a statistical significant difference between the two groups (P = 0.001) for the Il-
10 SNP-819 C/T (rs #3021097). The genotype CT in cases considers risk factor while TT genotype among 
control consider protective from the disease as shown in table 2. 
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Table 2: IL-10 gene polymorphism and allele frequencies among T2DM patients and their control 
Gene polymorphism 
Cases Control 
Significance OR (95% CI) 
No. % No. % 
Il-10 
SNP-819  C/T 
(rs #3021097) 
    
X2 = 12.053 
P = 0.001 
 
CC 32 20.9 36 30.0 (1.495 - 3.609) 
TT 19 15.8 43 35.9 (0.277 - 0.669) 
CT 76 63.3 41 34.1  
X2: Chi-Square test                       *significant at P≤0.05     
T2DM  known  as  an  immune  mediated  disease leading  to  defect  insulin  signaling  and  selective  
destruction  of  insulin  producing  beta  cells  in  which  cytokines  play  an  important  role  (Pickup, 2004).   
Interleukin -10 (IL-10)  is an important immunoregulatory cytokine that is produced by activated T cells (Del 
Prete et al., 1993). It plays an important role in activation and suppressing the immune response and functions as 
an immune response modulator (Chagas et al., 2013; Helminen, Lahdenpohja, and Hurme, 1999; Jin et al., 2013). 
In recent study showed that meta-analysis provides strong evidence that IL-10 -1082A/G polymorphism 
associated with risk of T2DM. while, no association of the IL-10 - 592C/A or - 819C/T polymorphism with 
T2DM risk (Hua et al., 2013). Otherwise no significant found in the A-592C (p=0.088) or T-819C (p=0.160) 
polymorphism and T2DM, significantly more T2DM subjects carried -592*C (34.28%, p=0.027) and -819*C 
(32.57%, p<0.001) alleles, which were associated with high levels of IL-10 production. Previous study suggests 
that IL-10 genetic polymorphisms may play a specific role in determining diabetic susceptibility, but do not 
seem to be important in the clinical manifestations of diabetes  (Chang et al., 2005). On the other hand decreased 
prevalence of (mutant) –819T allele and –819C/T genotype was seen in diabetes nephropathy patients; neither 
the –1082G/A nor the –592C/A polymorphism was associated with diabetes nephropathy in Tunisian patients 
(Ezzidi et al., 2009). Recent studies have documented several polymorphic sites in the IL-10 gene promoter 
region upstream of the transcription start site, including three polymorphisms at positions -1082 A/G, -819 C/T 
and -592 A/C (Zhang, Li, and Yang, 2006). Others studies have found an association between IL 10 genetic 
polymorphism and the risk T2DM (Del Prete et al., 1993; Garcia-Elorriaga et al., 2013; Kolla et al., 2009; Li et 
al., 2013; Yin et al., 2012). In conclusion, the findings of this present study suggest that the IL10-819 C/T gene 
polymorphisms increase the risk for type 2 diabetes mellitus in Iraqis population. 
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